Clinical Trial Update: Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus [Phase 1]

View source ↗

Summary

A Phase 1b/II trial evaluating pembrolizumab plus intensity-modulated radiotherapy (IMRT) for stage III/IV anal cancer. The study is active but not currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Cardiff University | Conditions: Anal Cancer Stage III A, Anal Cancer Stage III B | Phase 1 | Status: ACTIVE_NOT_RECRUITING